前收市價 | 159.64 |
開市 | 159.75 |
買盤 | 160.75 x 800 |
賣出價 | 160.90 x 800 |
今日波幅 | 159.48 - 161.58 |
52 週波幅 | 143.13 - 175.97 |
成交量 | |
平均成交量 | 7,306,390 |
市值 | 386.609B |
Beta 值 (5 年,每月) | 0.52 |
市盈率 (最近 12 個月) | 24.30 |
每股盈利 (最近 12 個月) | 6.61 |
業績公佈日 | 2024年10月15日 |
遠期股息及收益率 | 4.96 (3.11%) |
除息日 | 2024年8月27日 |
1 年預測目標價 | 158.02 |
Nvidia, a pioneer in the semiconductor and artificial intelligence space, is increasingly looking to leverage those skills toward transforming healthcare.
AbbVie's (ABBV) second-quarter earnings and sales beat estimates. Management hikes the EPS guidance on encouraging product sales for immunology drugs.
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.